Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market (2025-2031) | Forecast, Share, Competitive Landscape, Segmentation, Trends, Size & Revenue, Industry, Value, Analysis, Outlook, Companies, Growth

Name: Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market (2025-2031) | Forecast & Share
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By GLP-1 Receptor Agonists (Exenatide, Liraglutide (Victoza), Lixisenatide (Lyxumia), Dulaglutide (Trulicity), Semaglutide (Ozempic)), By Insulin Drugs (Basal or Long-acting Insulins, Bolus or Fast-acting Insulins, Traditional Human Insulins, Combination Insulins, Biosimilar Insulins) And Competitive Landscape

Product Code: ETC7632264	Publication Date: Sep 2024	Updated Date: Nov 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Vasudha	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Ireland Insulin Drugs and Glucagon-like Peptide 1 (Glp-1) Receptor Agonist Market Top 5 Importing Countries and Market Competition (HHI) Analysis

The import shipments of insulin drugs and GLP-1 receptor agonists to Ireland in 2024 saw significant growth, with the top exporting countries being Germany, UK, USA, Canada, and Areas, nes. The market concentration, as indicated by the HHI, increased from moderate to high in 2024. The compound annual growth rate (CAGR) from 2020 to 2024 was impressive at 23.25%, while the growth rate from 2023 to 2024 spiked to 68.68%. These trends suggest a thriving market for insulin drugs and GLP-1 receptor agonists in Ireland, with strong potential for continued expansion.

Ireland Insulin Drugs and Glucagon-like Peptide 1 (Glp-1) Receptor Agonist Market Top 5 Importing Countries and Market Competition (HHI) Analysis

Key Highlights of the Report:

Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Outlook
Market Size of Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market, 2024
Forecast of Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market, 2031
Historical Data and Forecast of Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Revenues & Volume for the Period 2021- 2031
Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Trend Evolution
Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Drivers and Challenges
Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Price Trends
Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Porter's Five Forces
Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Industry Life Cycle
Historical Data and Forecast of Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By GLP-1 Receptor Agonists for the Period 2021- 2031
Historical Data and Forecast of Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Exenatide for the Period 2021- 2031
Historical Data and Forecast of Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Liraglutide (Victoza) for the Period 2021- 2031
Historical Data and Forecast of Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Lixisenatide (Lyxumia) for the Period 2021- 2031
Historical Data and Forecast of Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Dulaglutide (Trulicity) for the Period 2021- 2031
Historical Data and Forecast of Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Semaglutide (Ozempic) for the Period 2021- 2031
Historical Data and Forecast of Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Insulin Drugs for the Period 2021- 2031
Historical Data and Forecast of Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Basal or Long-acting Insulins for the Period 2021- 2031
Historical Data and Forecast of Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Bolus or Fast-acting Insulins for the Period 2021- 2031
Historical Data and Forecast of Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Traditional Human Insulins for the Period 2021- 2031
Historical Data and Forecast of Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Combination Insulins for the Period 2021- 2031
Historical Data and Forecast of Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Biosimilar Insulins for the Period 2021- 2031
Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Import Export Trade Statistics
Market Opportunity Assessment By GLP-1 Receptor Agonists
Market Opportunity Assessment By Insulin Drugs
Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Top Companies Market Share
Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Competitive Benchmarking By Technical and Operational Parameters
Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Company Profiles
Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Overview

3.1 Ireland Country Macro Economic Indicators

3.2 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, 2021 & 2031F

3.3 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market - Industry Life Cycle

3.4 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market - Porter's Five Forces

3.5 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume Share, By GLP-1 Receptor Agonists, 2021 & 2031F

3.6 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume Share, By Insulin Drugs, 2021 & 2031F

4 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of diabetes in Ireland

4.2.2 Growing awareness about diabetes management and treatment options

4.2.3 Technological advancements in insulin delivery systems and GLP-1 receptor agonists

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approval

4.3.2 High cost associated with insulin and GLP-1 receptor agonist therapies

4.3.3 Limited accessibility to specialized diabetes care centers in some regions of Ireland

5 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Trends

6 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market, By Types

6.1 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market, By GLP-1 Receptor Agonists

6.1.1 Overview and Analysis

6.1.2 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By GLP-1 Receptor Agonists, 2021- 2031F

6.1.3 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By Exenatide, 2021- 2031F

6.1.4 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By Liraglutide (Victoza), 2021- 2031F

6.1.5 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By Lixisenatide (Lyxumia), 2021- 2031F

6.1.6 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By Dulaglutide (Trulicity), 2021- 2031F

6.1.7 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By Semaglutide (Ozempic), 2021- 2031F

6.2 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market, By Insulin Drugs

6.2.1 Overview and Analysis

6.2.2 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By Basal or Long-acting Insulins, 2021- 2031F

6.2.3 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By Bolus or Fast-acting Insulins, 2021- 2031F

6.2.4 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By Traditional Human Insulins, 2021- 2031F

6.2.5 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By Combination Insulins, 2021- 2031F

6.2.6 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By Biosimilar Insulins, 2021- 2031F

7 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Import-Export Trade Statistics

7.1 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Export to Major Countries

7.2 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Imports from Major Countries

8 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Key Performance Indicators

8.1 Average HbA1c reduction rate among patients using insulin and GLP-1 receptor agonists

8.2 Number of new diabetes diagnoses in Ireland

8.3 Patient adherence rate to prescribed insulin and GLP-1 receptor agonist therapies

9 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market - Opportunity Assessment

9.1 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Opportunity Assessment, By GLP-1 Receptor Agonists, 2021 & 2031F

9.2 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Opportunity Assessment, By Insulin Drugs, 2021 & 2031F

10 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market - Competitive Landscape

10.1 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenue Share, By Companies, 2024

10.2 Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Global Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market

Tonga Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market

Trinidad and Tobago Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market

Turkmenistan Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market

Tuvalu Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market

Ukraine Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market